Larynx Cancer Biomarkers
Over the last 30 years, the occurrence of head and neck cancer in Spain has been increasing, and now accounts for between 5–10% of malignant tumours diagnosed each year.1 In a new study published in the journal Chromatographia, solid-phase microextraction (SPME) with gas chromatography coupled to mass spectrometry (GC–MS) has been performed to identify two potential biomarkers of epidermoid laryngeal cancer, that could be used in non-invasive diagnostic testing.
Photo Credit: Getty Images/Science Photo Library – PIXOLOGICSTUDIO
Over the last 30 years, the occurrence of head and neck cancer in Spain has been increasing, and now accounts for between 5–10% of malignant tumours diagnosed each year.1 In a new study published in the journal Chromatographia, solid-phase microextraction (SPME) with gas chromatography coupled to mass spectrometry (GC–MS) has been performed to identify two potential biomarkers of epidermoid laryngeal cancer, that could be used in non-invasive diagnostic testing.
Adolfo Toledano, an otolaryngologist from the Alcorcón hospital (Madrid, Spain), approached Rafael García from Rey Juan Carlos University (Madrid, Spain) with the idea of applying volatile compound analysis to the exhaled breath of patients as a method of diagnosing head and neck cancers. García told The Column: “Previously, I had been working on the detection of volatile organic compounds (VOCs) for environmental applications, and the chance to detect these organic compounds from the exhaled air of patients suffering epidermoid laryngeal carcinomas, as non-invasive biomarkers to be used in early detection of this pathology, was an outstanding challenge.”
A group of 31 volunteers were recruited for the study: 20 healthy volunteers, and 11 patients diagnosed with cancer of the larynx undergoing treatment at Alcorcón Hospital. Samples were collected from patients exhaling air after an 8 hr fast using gas sampling bags. SPME was performed to concentrate compounds within the exhaled air, before analysis using GC–MS.
The method was able to detect seven potential biomarkers that were at different concentrations between healthy and diagnosed patients. However, only two were considered to be significantly higher in late-stage cancer patients (T3) when compared with healthy or early-stage patients (T1) — ethanol and 2-butanone.
There is a note of caution from García who said: “The importance of the work is quite relative and it is important to be cautious, since the evaluated subjects are not statistically significant enough to extract definitive conclusions, and also because the more significant VOCs were detected in the later stages of the disease. However, the importance of the investigation is the concept, not only for this serious pathology but also from other neck and head prevalent diseases. I am sure that the results are widely improvable, and it will be improved.”– B.D.
Reference
1. R. García, V. Morales, and Sergio Martín, Chromatographia77, 501–509 (2014).
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
